Related Experiment Video
Updated: Jun 6, 2025
Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
Published on: January 19, 2024
Efficacy and Safety of Combination Therapy of Microneedling Radiofrequency, In-Office and Home-Based Topical
Ya-Wen Tsai1,2,3, Jeng-Hsien Lin4, Yi-Jing Lai1,2,3
1School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Background:
Refractory melasma remains a challenge in dermatology, necessitating the exploration of innovative treatments.
Aims:
This study aims to evaluate the efficacy and safety of combining radiofrequency microneedling (RFM) with Cysteamine cream, applied both in-office and as a part of a home-care regimen, to treat refractory melasma.
Patients/Methods:
A vehicle-controlled, split-face trial was conducted on 30 Fitzpatrick skin types III and IV participants. Subjects received RFM and Cysteamine serum on one side of the face and RFM with saline on the contralateral side. Additionally, a random half-added Cysteamine cream was applied at home. The modified Melasma Area and Severity Index and VISIA skin analysis were used for assessment.
Results:
Significant improvement in melasma severity and skin texture was noted on the sides treated with RFM and Cysteamine, including observable benefits from both in-office and home-based Cysteamine use with minimal adverse effects.
Conclusions:
The combined approach of RFM with Cysteamine provides a promising and safe modality for managing refractory melasma, showing notable improvements.
